PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
09-Dec-2019 AEVIS VICTORIA SA: Sale of Générale Beaulieu Immobilière SA to Infracore SA AEVIS VICTORIA SA
09-Dec-2019 Medartis provides update on Brazil investigation Medartis Holding AG
08-Dec-2019 Lilly Presents Interim Clinical Data from LOXO-305 Dose Escalation Trial in B-Cell Leukemias and Lymphomas at the American Society Hematology Annual Meeting Eli Lilly and Company
08-Dec-2019 Portola Pharmaceuticals Presents New Interim Data from Ongoing Phase 2a Study of its Oral SYK/JAK Inhibitor Cerdulatinib in Heavily Pre-Treated T-Cell Malignancies Portola Pharmaceuticals, Inc.®
08-Dec-2019 Viracta Announces Positive Phase 1b/2 Data Presented at Oral Presentation on Lead Program for Epstein-Barr Virus (EBV)-associated Relapsed/Refractory Lymphomas at the 2019 American Society of Hematology (ASH) Annual Meeting Viracta Therapeutics, Inc.
08-Dec-2019 New Long-Term Data Continues to Demonstrate Progression-Free Survival and Overall Survival Benefits with VENCLEXTA®/ VENCLYXTO® (venetoclax) Combination in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) AbbVie
07-Dec-2019 Oncopeptides Presents Updated Efficacy and Safety Data from Pivotal Phase 2 HORIZON Study in Patients With RRMM at ASH Annual Meeting 2019 Oncopeptides AB
07-Dec-2019 Janssen to Acquire Investigational Bermekimab from XBiotech Janssen Pharmaceutical Companies of Johnson & Johnson
06-Dec-2019 Grifols presents its latest Alzheimer's clinical trial data Grifols
06-Dec-2019 LPCN INVESTOR ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Lipocine Inc. Bernstein Liebhard LLP
06-Dec-2019 LPCN INVESTOR ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Lipocine Inc. Bernstein Liebhard LLP
06-Dec-2019 Inland Empire Health Plan (IEHP) Passes CMS Formulary Review IEHP
06-Dec-2019 Curis Announces Positive Safety, Tolerability and Pharmacokinetic Data in Ongoing Phase 1 Study of Fimepinostat in Combination with Venetoclax Curis, Inc.
06-Dec-2019 Bimekizumab Phase 3 Psoriasis Study Demonstrates Superiority Versus Humira® UCB, Inc.
06-Dec-2019 VERFORA awarded European Launch of the Year VERFORA
06-Dec-2019 Biovica Strengthens Management Team Biovica International AB
05-Dec-2019 CannTrust Provides Default Status Report and Other Updates CannTrust Holdings Inc.
05-Dec-2019 PhRMA Names Anne Esposito Senior Vice President of Federal Advocacy Pharmaceutical Research and Manufacturers of America (PhRMA)
05-Dec-2019 Inceptua appoints new President North America Inceptua
05-Dec-2019 Black Diamond Therapeutics Closes $85 Million Series C Financing Black Diamond Therapeutics, Inc.